BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Verma V, Rwigema JM, Malyapa RS, Regine WF, Simone CB. Systematic assessment of clinical outcomes and toxicities of proton radiotherapy for reirradiation. Radiotherapy and Oncology 2017;125:21-30. [DOI: 10.1016/j.radonc.2017.08.005] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Barsky AR, Reddy VK, Plastaras JP, Ben-Josef E, Metz JM, Wojcieszynski AP. Proton beam re-irradiation for gastrointestinal malignancies: a systematic review. J Gastrointest Oncol 2020;11:187-202. [PMID: 32175122 DOI: 10.21037/jgo.2019.09.03] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Menon H, Guo C, Verma V, Simone CB 2nd. The Role of Positron Emission Tomography Imaging in Radiotherapy Target Delineation. PET Clin 2020;15:45-53. [PMID: 31735301 DOI: 10.1016/j.cpet.2019.08.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Gupta A, Khan AJ, Goyal S, Millevoi R, Elsebai N, Jabbour SK, Yue NJ, Haffty BG, Parikh RR. Insurance Approval for Proton Beam Therapy and its Impact on Delays in Treatment. International Journal of Radiation Oncology*Biology*Physics 2019;104:714-23. [DOI: 10.1016/j.ijrobp.2018.12.021] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
4 Decesaris CM, Mccarroll R, Mishra MV, Glass E, Greenwald BD, Carr S, Burrows W, Mehra R, Regine WF, Simone CB, Choi JI, Molitoris JK. Assessing Outcomes of Patients Treated With Re-Irradiation Utilizing Proton Pencil-Beam Scanning for Primary or Recurrent Malignancies of the Esophagus and Gastroesophageal Junction. Journal of Thoracic Oncology 2020;15:1054-64. [DOI: 10.1016/j.jtho.2020.01.024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
5 Ning MS, Palmer MB, Shah AK, Chambers LC, Garlock LB, Melson BB, Frank SJ. Three-Year Results of a Prospective Statewide Insurance Coverage Pilot for Proton Therapy: Stakeholder Collaboration Improves Patient Access to Care. JCO Oncol Pract 2020;16:e966-76. [PMID: 32302271 DOI: 10.1200/JOP.19.00437] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Régnier E, Laprie A, Ducassou A, Bolle S, Supiot S, Muracciole X, Claude L, Chapet S, Coche-dequéant B, Vigneron C, Leseur J, Bondiau PY, Habrand JL, Bernier V. Re-irradiation of locally recurrent pediatric intracranial ependymoma: Experience of the French society of children’s cancer. Radiotherapy and Oncology 2019;132:1-7. [DOI: 10.1016/j.radonc.2018.11.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
7 Liu Z, Chen Y, Su Y, Hu X, Peng X. Nasopharyngeal Carcinoma: Clinical Achievements and Considerations Among Treatment Options. Front Oncol 2021;11:635737. [PMID: 34912697 DOI: 10.3389/fonc.2021.635737] [Reference Citation Analysis]
8 Fischer-Valuck BW, Robinson CG, Simone CB 2nd, Gomez DR, Bradley JD. Challenges in Re-Irradiation in the Thorax: Managing Patients with Locally Recurrent Non-Small Cell Lung Cancer. Semin Radiat Oncol 2020;30:223-31. [PMID: 32503787 DOI: 10.1016/j.semradonc.2020.02.001] [Reference Citation Analysis]
9 Dionisi F, Croci S, Giacomelli I, Cianchetti M, Caldara A, Bertolin M, Vanoni V, Pertile R, Widesott L, Farace P, Schwarz M, Amichetti M. Clinical results of proton therapy reirradiation for recurrent nasopharyngeal carcinoma. Acta Oncol 2019;58:1238-45. [PMID: 31155998 DOI: 10.1080/0284186X.2019.1622772] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 4.7] [Reference Citation Analysis]
10 Verma V, Choi JI, Sawant A, Gullapalli RP, Chen W, Alavi A, Simone CB. Use of PET and Other Functional Imaging to Guide Target Delineation in Radiation Oncology. Seminars in Radiation Oncology 2018;28:171-7. [DOI: 10.1016/j.semradonc.2018.02.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
11 Alterio D, Marvaso G, Ferrari A, Volpe S, Orecchia R, Jereczek-Fossa BA. Modern radiotherapy for head and neck cancer. Semin Oncol 2019;46:233-45. [PMID: 31378376 DOI: 10.1053/j.seminoncol.2019.07.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
12 Grau C, Baumann M, Weber DC. Optimizing clinical research and generating prospective high-quality data in particle therapy in Europe: Introducing the European Particle Therapy Network (EPTN). Radiother Oncol 2018;128:1-3. [PMID: 30049367 DOI: 10.1016/j.radonc.2018.06.021] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
13 Chao HH, Berman AT. Proton therapy for thoracic reirradiation of non-small cell lung cancer. Transl Lung Cancer Res 2018;7:153-9. [PMID: 29876314 DOI: 10.21037/tlcr.2018.03.22] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Svajdova M, Dubinsky P, Kazda T. Radical external beam re-irradiation in the treatment of recurrent head and neck cancer: Critical review. Head Neck 2021;43:354-66. [PMID: 32996265 DOI: 10.1002/hed.26485] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Choi JI, Khan AJ, Powell SN, McCormick B, Lozano AJ, Del Rosario G, Mamary J, Liu H, Fox P, Gillespie E, Braunstein LZ, Mah D, Cahlon O. Proton reirradiation for recurrent or new primary breast cancer in the setting of prior breast irradiation. Radiother Oncol 2021;165:142-51. [PMID: 34688807 DOI: 10.1016/j.radonc.2021.10.010] [Reference Citation Analysis]
16 Verma V, Haque W, Zheng D, Osayande F, Lin C. Patterns of Care and Outcomes of Elderly Esophageal Cancer Patients Not Meeting Age-based Criteria of the CROSS Trial. Am J Clin Oncol 2019;42:67-74. [PMID: 30216194 DOI: 10.1097/COC.0000000000000481] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
17 Trybula SJ, Youngblood MW, Kemeny HR, Clark JR, Karras CL, Hartsell WF, Tomita T. Radiation Induced Cavernomas in the Treatment of Pediatric Medulloblastoma: Comparative Study Between Proton and Photon Radiation Therapy. Front Oncol 2021;11:760691. [PMID: 34707999 DOI: 10.3389/fonc.2021.760691] [Reference Citation Analysis]
18 Fattahi S, Ahmed SK, Park SS, Petersen IA, Shumway DA, Stish BJ, Yan ES, Remmes NB, Mutter RW, Corbin KS. Reirradiation for Locoregional Recurrent Breast Cancer. Adv Radiat Oncol 2021;6:100640. [PMID: 33506143 DOI: 10.1016/j.adro.2020.100640] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
19 Luo W, Ali YF, Liu C, Wang Y, Liu C, Jin X, Zhou G, Liu NA. Particle Therapy for Breast Cancer: Benefits and Challenges. Front Oncol 2021;11:662826. [PMID: 34026640 DOI: 10.3389/fonc.2021.662826] [Reference Citation Analysis]
20 Pötter R, Balosso J, Baumann M, Bert C, Davies J, Enghardt W, Fossati P, Harris S, Jones B, Krämer M, Mayer R, Mock U, Pullia M, Schreiner T, Dosanjh M, Debus J, Orecchia R, Georg D. Union of light ion therapy centers in Europe (ULICE EC FP7) – Objectives and achievements of joint research activities. Radiotherapy and Oncology 2018;128:83-100. [DOI: 10.1016/j.radonc.2018.04.027] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
21 Peddada KV, Sangani R, Menon H, Verma V. Complications and adverse events of plaque brachytherapy for ocular melanoma. J Contemp Brachytherapy 2019;11:392-7. [PMID: 31523242 DOI: 10.5114/jcb.2019.87407] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
22 Ren C, Ji T, Liu T, Dang J, Li G. The risk and predictors for severe radiation pneumonitis in lung cancer patients treated with thoracic reirradiation. Radiat Oncol 2018;13:69. [PMID: 29661254 DOI: 10.1186/s13014-018-1016-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
23 Taugner J, Eze C, Käsmann L, Roengvoraphoj O, Gennen K, Karin M, Petrukhnov O, Tufman A, Belka C, Manapov F. Pattern-of-failure and salvage treatment analysis after chemoradiotherapy for inoperable stage III non-small cell lung cancer. Radiat Oncol 2020;15:148. [PMID: 32517716 DOI: 10.1186/s13014-020-01590-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
24 Shaaban SG, Verma V, Choi JI, Shabason J, Sharma S, Glass E, Grover S, Badiyan SN, Simone CB 2nd. Utilization of Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma in the United States. Clin Lung Cancer. 2018;19:e685-e692. [PMID: 29803576 DOI: 10.1016/j.cllc.2018.04.019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
25 Badiyan SN, Rutenberg MS, Hoppe BS, Mohindra P, Larson G, Hartsell WF, Tsai H, Zeng J, Rengan R, Glass E, Katz S, Vargas C, Feigenberg SJ, Simone CB 2nd. Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies. Pract Radiat Oncol. 2019;9:280-288. [PMID: 30802618 DOI: 10.1016/j.prro.2019.02.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
26 Haque W, Verma V, Fakhreddine M, Butler EB, Teh BS, Simone CB 2nd. Trends in Cardiac Mortality in Patients With Locally Advanced Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 2018;100:470-7. [PMID: 29353659 DOI: 10.1016/j.ijrobp.2017.10.031] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
27 Hwang EJ, Gorayski P, Le H, Hanna GG, Kenny L, Penniment M, Buck J, Thwaites D, Ahern V. Particle therapy tumour outcomes: An updated systematic review. J Med Imaging Radiat Oncol 2020;64:711-24. [PMID: 32270626 DOI: 10.1111/1754-9485.13021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Thorpe CS, Niska JR, Girardo ME, Kosiorek HE, McGee LA, Hartsell WF, Larson GL, Tsai HK, Rossi CJ, Rosen LR, Vargas CE. Proton beam therapy reirradiation for breast cancer: Multi-institutional prospective PCG registry analysis. Breast J 2019;25:1160-70. [PMID: 31338974 DOI: 10.1111/tbj.13423] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
29 Lazarev S, Rosenzweig K, Samstein R, Salgado LR, Hasan S, Press RH, Sharma S, Powell CA, Hirsch FR, Simone CB 2nd. Where are we with proton beam therapy for thoracic malignancies? Current status and future perspectives. Lung Cancer 2021;152:157-64. [PMID: 33421922 DOI: 10.1016/j.lungcan.2020.12.025] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Ryckman JM, Ganesan V, Kusi Appiah A, Zhang C, Verma V. National practice patterns of proton versus photon therapy in the treatment of adult patients with primary brain tumors in the United States. Acta Oncol 2019;58:66-73. [PMID: 30280620 DOI: 10.1080/0284186X.2018.1512755] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
31 Verma V, Choi JI, Simone CB 2nd. Proton therapy for small cell lung cancer. Transl Lung Cancer Res 2018;7:134-40. [PMID: 29876312 DOI: 10.21037/tlcr.2018.04.02] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
32 Nieder C, Yobuta R, Mannsåker B. Second Re-irradiation: Clinical Examples of Worthwhile Treatment. Cureus 2018;10:e2813. [PMID: 30128218 DOI: 10.7759/cureus.2813] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Simone CB 2nd, Plastaras JP, Jabbour SK, Lee A, Lee NY, Choi JI, Frank SJ, Chang JY, Bradley J. Proton Reirradiation: Expert Recommendations for Reducing Toxicities and Offering New Chances of Cure in Patients With Challenging Recurrence Malignancies. Semin Radiat Oncol 2020;30:253-61. [PMID: 32503791 DOI: 10.1016/j.semradonc.2020.02.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
34 Vyfhuis MAL, Rice S, Remick J, Mossahebi S, Badiyan S, Mohindra P, Simone CB 2nd. Reirradiation for locoregionally recurrent non-small cell lung cancer. J Thorac Dis 2018;10:S2522-36. [PMID: 30206496 DOI: 10.21037/jtd.2017.12.50] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
35 Brooks ED, Wang X, De B, Verma V, Williamson TD, Hunter R, Mohamed ASR, Ning MS, Zhang X, Chang JY. An algorithm for thoracic re-irradiation using biologically effective dose: a common language on how to treat in a "no-treat zone". Radiat Oncol 2022;17:4. [PMID: 34991637 DOI: 10.1186/s13014-021-01977-1] [Reference Citation Analysis]
36 Troost EGC, Wink KCJ, Roelofs E, Simone CB 2nd, Makocki S, Löck S, van Kollenburg P, Dechambre D, Minken AWH, van der Stoep J, Avery S, Jansen N, Solberg T, Bussink J, de Ruysscher D. Photons or protons for reirradiation in (non-)small cell lung cancer: Results of the multicentric ROCOCO in silico study. Br J Radiol 2020;93:20190879. [PMID: 31804145 DOI: 10.1259/bjr.20190879] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
37 Seidensaal K, Harrabi SB, Uhl M, Debus J. Re-irradiation with protons or heavy ions with focus on head and neck, skull base and brain malignancies. Br J Radiol 2020;93:20190516. [PMID: 31647306 DOI: 10.1259/bjr.20190516] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]